Professional Documents
Culture Documents
2020-01-14 Letter
2020-01-14 Letter
S U BS CRIBER L E TTER
ASSESSING MARKET ACTION WITH INDICATORS AND HISTORY
Market Overview
Signals Overview
Aggregator CBI Reading
Flat 0
Short-term Outlook
The Bottom Line
Too overbought to buy and too strong to short.
The Evidence
The market gapped up on Monday and continued upwards, finishing near the high or the day, and
at all-times highs for several indices. The SPX rose 0.7%, NASDAQ gained 1.0% and Russell
2000 climbed 0.7%. Breadth was positive as the NYSE Up Issues % was 69% and the Up Volume
% came in at 65%. NYSE volume rose some from Friday’s level.
Compelling new short-term evidence tonight is lacking. Sometimes when the market gets into
these persistent moves higher, we just don’t see compelling triggers one way or the other. “Too
overbought to buy and too strong to short” is a phrase I have used many times. But while there is
nothing new and compelling tonight, let’s briefly review some of the evidence we have seen
recently that might be worth remaining aware of.
The intermediate-term active list is filled with bullish studies. Momentum, the Fed, a leading
NASDAQ, and long-term cycles all support the idea that the rally should continue. But we have
seen evidence recently suggesting it could be overdone, and that mid-January is a time where it
could pull back. Over the weekend I showed how January opex week had struggled historically.
And while it has not been the case in recent years, that tendency could reassert itself. In the 1/3/20
letter I showed that there has often been a mid-January swoon when the 1st trading day of the year
has started with a gain. That swoon has not yet arrived. I have also noted that SPY and QQQ have
gone an extended period now without any substantial pullback. They have now both closed above
their 10-day moving averages for 25 days in a row. Since 2000, there have only been 3 other
instances where this has happened: 11/2014, 11/2015, and 3/2016. So a pullback is overdue, and
mid-January is often a time where we see one. Therefore, there is a battle between time frames and
bullish/bearish forces, and finding a great trigger point is tough here.
With the short-term active list barren, expectations are solely based on the intermediate-term
studies. If nothing new emerges on Tuesday, then they will remain slightly bullish. Of course short-
term expectations in the coming days will be greatly influenced by any new short-term evidence
that emerges. Meanwhile, the Differential Pivot will be 3269.61 on Tuesday. That is 0.6% below
Monday’s close. Therefore, SPX would need to close 0.6% lower in order to flip back to
“oversold” versus recent expectations.
So the Aggregator is again neutral. I am too. And my outlook has not really changed since
yesterday. Like I said above…too overbought to buy and too strong to short. I will continue to
wait for a more favorable reward/risk opportunity before taking on new index exposure. The
market rarely goes very long without tipping its hand in some way. I’ll be ready when it does.
OpenCatapult Triggers
None
None tonight.
This report has been prepared by Quantifiable Edges, LLC and is provided for information purposes only. Under no circumstances is it to be used
or considered as an offer to sell, or a solicitation of any offer to buy securities. While information contained herein is believed to be accurate at the
time of publication, we make no representation as to the accuracy or completeness of any data, studies, or opinions expressed and it should not be
relied upon as such. Robert Hanna, Quantifiable Edges, LLC or clients of Quantifiable Edges, LLC may have positions or other interests in
securities (including derivatives) directly or indirectly which are the subject of this report. This report is provided solely for the information of
Quantifiable Edges, LLC clients and prospects who are expected to make their own investment decisions without reliance upon this report. Neither
Quantifiable Edges, LLC nor any officer or employee of Quantifiable Edges, LLC accepts any liability whatsoever for any direct or consequential
loss arising from any use of this report or its contents. This report may not be reproduced, distributed or published by any recipient for any purpose
without the prior express consent of Quantifiable Edges, LLC.